| PERIOD ENDING | 30-Jan-09 | 1-Feb-08 | 2-Feb-07 | | Total Revenue | 61,101,000 | 61,133,000 | 57,420,000 | | Cost of Revenue | 50,144,000 | 49,462,000 | 47,904,000 | | | Gross Profit | 10,957,000 | 11,671,000 | 9,516,000 | | | Operating Expenses | | Research Development | 663,000 | 610,000 | 498,000 | | Selling General and Administrative | 7,102,000 | 7,538,000 | 5,948,000 | | Non Recurring | 2,000 | 83,000 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 3,190,000 | 3,440,000 | 3,070,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 227,000 | 461,000 | 343,000 | | Earnings Before Interest And Taxes | 3,417,000 | 3,872,000 | 3,390,000 | | Interest Expense | 93,000 | 45,000 | 45,000 | | Income Before Tax | 3,324,000 | 3,827,000 | 3,345,000 | | Income Tax Expense | 846,000 | 880,000 | 762,000 | | Minority Interest |
-
| (29,000) | (23,000) | | | | Net Income From Continuing Ops | 2,478,000 | 2,947,000 | 2,583,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 2,478,000 | 2,947,000 | 2,583,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,478,000 | $2,947,000 | $2,583,000 |
|
1.29% Nasdaq 0.00%
Income Statement
